Physician profile
Usha Rao
NPI 1952627010
$1,565.43
in general payments reported to CMS, 2019-2025
15 companies · $801 in 2025
The $801 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $228 · 2024: $537 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $409.67 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.89 | 2023-2025 | Ofev, Jascayd |
| Genzyme Corporation | $204.80 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $153.01 | 2023-2025 | Fasenra, Imfinzi, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $80.84 | 2024-2025 | Glassia |
| United Therapeutics Corporation | $64.21 | 2024-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $63.79 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $60.05 | 2023-2024 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $59.85 | 2025 | Dupixent |
| Insmed, INC. | $42.31 | 2025 | Arikayce |
| Grifols USA, LLC | $36.34 | 2024 | Prolastin-C Liquid |
| Vifor Pharma, INC. | $26.41 | 2024 | Veltassa |
| Viatris Specialty LLC | $25.43 | 2025 | Yupelri |
| Alexion Pharmaceuticals, INC. | $21.87 | 2025 | Ultomiris |
| Philips North America LLC | $14.96 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usha Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.